Clinical Trial Update: A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating two tegafur-based regimens—tegafur with temozolomide alone versus tegafur with temozolomide plus thalidomide—in advanced pancr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Temozolomide (Temozolomide)
• Thalidomide (thalidomide)
• tegafur (tegafur)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Pancreatic Neuroendocrine Tumor | Phase 2 | Status: UNKNOWN